Daly Richard J
- SEC CIK
- 0001635393
No open-market purchases or sales filed in the past year.
Current role at each company
- CPRX Catalyst Pharmaceuticals, Inc.President and CEOas of Jul 17, 2026
- OPNT Opiant Pharmaceuticals, Inc.Directoras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Daly Richard J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CPRX Catalyst Pharmaceuticals, Inc.
President and CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 (view filing) | Aug 26 | 2 days | Daly Richard JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −23.0K | $20.62 | −$473.6K | −9.2%226.8K after | |
| Jun 3, 2025 (view filing) | May 30 | 4 days | Daly Richard JPresident and CEO | SSaleCommon stock, par value $0.001 per share | +70.0K | $24.86 | +$1.74M | +53.9%199.8K after | |
| Jun 5, 2024 (view filing) | Jun 4 | 1 day | Daly Richard JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −17.3K | $15.98 | −$276.8K | −6.9%234.8K after |